This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignee: Remegen, Ltd.. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2026
Title: Zhuanglin Li: Innovator in Anti-HER2 Antibody Development
Introduction
Zhuanglin Li is a prominent inventor based in Yantai, China. He is recognized for his significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies.
Latest Patents
Zhuanglin Li holds a patent for an anti-HER2 antibody and its conjugate. This patent discloses an anti-HER2 antibody and a conjugate of the antibody with small molecule medicine. The invention also outlines the uses of the antibody and its conjugate in preparing medicine for treating tumors. This innovation represents a crucial advancement in cancer treatment.
Career Highlights
Throughout his career, Zhuanglin Li has worked with notable companies, including Remegen, Ltd. and Remegen Co., Ltd. His work in these organizations has contributed to the development of innovative medical solutions.
Collaborations
Zhuanglin Li has collaborated with esteemed colleagues such as Jianmin Fang and Changjiang Huang. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Zhuanglin Li's work in the field of anti-HER2 antibodies showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his innovations continue to inspire future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile